Wellgistics Health, Inc. (NASDAQ:WGRX) | Finanzwire

Basculer en Français

9526	Companies
187402	Keywords
119432	Articles
100169	Press releases

Headlines Articles Press releases Wellgistics Health, Inc.

Home
Companies
Wellgistics Health, Inc.

BRIEF

published on 11/12/2025 at 13:45, 1 month 3 days ago

Wellgistics Health Launches AI-Driven EinsteinRx Hub

Healthcare Integration Wellgistics Health EinsteinRx AI Prescription Management Pharmacy IT Railroad
PRESS RELEASE

published on 11/12/2025 at 13:40, 1 month 3 days ago

Wellgistics Health Launches EinsteinRx as the Premier AI Prescription Management Hub Solution to Integrate Physical and Technology Healthcare Infrastructure
Wellgistics Health, Inc. launches EinsteinRx™, a premier prescription management solution integrating physical & technology infrastructure for optimized healthcare delivery in the $634B US prescription drug market. Enables seamless flow of information from physician to pharmacy

Healthcare Delivery Wellgistics Health Inc. EinsteinRx Pharmacy IT Railroad Prescription Management
BRIEF

published on 10/13/2025 at 14:05, 2 months 2 days ago

Wellgistics Health Announces Key Executive and Board Restructuring

Financial Expertise Executive Changes Pharmaceutical Distribution Board Restructuring AI Strategy
PRESS RELEASE

published on 10/13/2025 at 14:00, 2 months 2 days ago

Wellgistics Health Announces Executive Management and Board Changes
Wellgistics Health, Inc. announces re-appointment of Prashant Patel as President and Interim-CEO. Eric Sherb appointed Interim-CFO. Changes in Board of Directors and executive management

Board Of Directors Pharmaceutical Distribution Wellgistics Health Prashant Patel Eric Sherb
BRIEF

published on 09/30/2025 at 14:05, 2 months 15 days ago

Wellgistics Health Collaborates with TheracosBio for Expanded Diabetes Medication Access

TheracosBio Pharmaceutical Distribution Wellgistics Health Diabetes Medication Brenzavvy®
PRESS RELEASE

published on 09/30/2025 at 14:00, 2 months 15 days ago

Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies
Wellgistics Health partners with TheracosBio to improve affordability and access to diabetes medication Brenzavvy in the U.S. healthcare system through their maker-to-taker platform and network of 6,500+ pharmacies

TheracosBio BRENZAVVY Pharmaceutical Distribution Wellgistics Health Diabetes Medication
BRIEF

published on 09/26/2025 at 02:06, 2 months 19 days ago

Wellgistics Health Announces $5 Million Public Offering Pricing

Public Offering Pharmaceutical Distribution Stock Warrants AI Services Wellgistics Health
PRESS RELEASE

published on 09/26/2025 at 02:01, 2 months 19 days ago

Wellgistics Health Announces Pricing of $5 Million Public Offering
Wellgistics Health, Inc. (NASDAQ: WGRX) announces pricing of public offering of 7,142,862 shares of common stock at $0.70 per share. Gross proceeds expected to be $5 million. Offering by H.C. Wainwright & Co

Public Offering H.C. Wainwright & Co. Pharmaceutical Distribution Wellgistics Health WGRX
BRIEF

published on 09/24/2025 at 14:05, 2 months 21 days ago

Wellgistics Health Launches Capital Access Program for Pharmacies and Partners

Capital Access Supply Chain Resilience Wellgistics Health RxERP Financial Pharmacies Financing
PRESS RELEASE

published on 09/24/2025 at 14:00, 2 months 21 days ago

Wellgistics Health Launches Capital Access Program for 6,500+ Pharmacies and Supply Chain Partners, Unlocking up to $1M in Working Capital
Wellgistics Health partners with RxERP Financial to offer capital access program for pharmacies and wholesalers, enhancing cash flow and supply chain resilience

Supply Chain Resilience Pharmacies Wellgistics Health RxERP Financial Capital Access Program

Accesswire

Published on 12/15/2025 at 15:00, 39 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 39 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 1 hour 9 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 1 hour 39 minutes ago

Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 2 hours 9 minutes ago

Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 15:14, 24 minutes ago

Edison issues report on Aberdeen Asian Income Fund (AAIF)
Published on 12/15/2025 at 15:00, 39 minutes ago

Partners Group’s announcement of AuM as of 31 December 2025
Published on 12/15/2025 at 14:56, 43 minutes ago

EQS-Adhoc: Wolford AG: Mandate of Ralf Polito as Member of the Management Board extended
Published on 12/15/2025 at 14:43, 56 minutes ago

Bilfinger SE: Share Buyback
Published on 12/15/2025 at 13:35, 2 hours 4 minutes ago

DeFi Technologies Announces Launch of Brazilian Depositary Receipts for Institutional Investors on B3 Exchange

Les Echos

Published on 12/15/2025 at 11:50, 3 hours 49 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 21 hours ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 09:15, 3 days 6 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 12/11/2025 at 19:23, 3 days 20 hours ago

Eiffage is joining the CAC 40 index
Published on 12/11/2025 at 08:30, 4 days 7 hours ago

Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe

View all LES ECHOS COMFI WIRE